Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kernel
With
Acacia Clinics
Age
18–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Accelerated TMS cohort
Adults aged 18-75 at the time of enrollment
Primary diagnosis of MDD as defined by the DSM-5
Determined by the clinic to be eligible for accelerated rTMS treatment and agrees to receive accelerated rTMS treatment
Agrees to start accelerated rTMS treatment in conjunction with study participation to capture baseline measurements
Has not received rTMS treatment in the past 1 month
Has not received SPRAVATO treatment in the past 1 month
Can speak and understand English
Ability to provide informed consent
Healthy controls cohort
Adults aged 18-75 at time of enrollment
Can speak and understand English
Ability to provide informed consent
You may not be if
All cohorts
Pregnant or may become pregnant during the treatment course
Unable or unwilling to wear the fNIRS headset
Has had electroconvulsive therapy (ECT) in the past 3 months
Major medical illnesses including neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, schizophrenia, or stroke.
Any other clinically significant medical condition that in the opinion of the clinician or study team, could affect patient safety, wellbeing, or the participant's ability to comply with study procedures.
Not an appropriate candidate for the study based on the discretion of the study investigator(s).
Healthy controls cohort only
Clinical diagnosis of depression in the past year
Undergoing any treatments for depression in the past year
Clareo Health | Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements
